Literature DB >> 21735477

Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1.

Tetsuro Yasui1, Jun Hirose, Shuichi Tsutsumi, Kozo Nakamura, Hiroyuki Aburatani, Sakae Tanaka.   

Abstract

Gene expression is controlled by epigenetic mechanisms such as histone acetylation and methylation, and recent studies have revealed that key developmental steps are regulated by the trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3). Using ChIP sequencing technology combined with real-time PCR, we here demonstrate that the H3K27me3 observed in the Nfatc1 gene in bone marrow-derived macrophages (BMMs) was markedly reduced in mature osteoclasts. Jumonji domain-containing 3 (Jmjd3), a H3K27 demethylase, was induced in bone marrow-derived macrophages and in the vicinity of the transcription start site (TSS) of nuclear factor-activated T cells (NFAT) c1 in response to receptor activator of nuclear factor-κB ligand (RANKL) stimulation. Gene silencing of the Jmjd3 gene by short hairpin RNA reduced demethylation of H3K27me3 at the TSS of Nfatc1 and suppressed RANKL-induced osteoclastogenesis. These results suggest that the demethylation of H3K27me3 in the Nfatc1 gene locus by Jmjd3 plays a critical role in RANKL-induced osteoclast differentiation.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735477     DOI: 10.1002/jbmr.464

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  49 in total

1.  Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development.

Authors:  Kaori Tsuji-Takechi; Takako Negishi-Koga; Eriko Sumiya; Akiko Kukita; Shigeaki Kato; Takahiro Maeda; Pier Paolo Pandolfi; Keiji Moriyama; Hiroshi Takayanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.

Authors:  Soon-Duck Ha; Chantelle Reid; Shahab Meshkibaf; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

3.  Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.

Authors:  Weijun Wu; Ming Qin; Wanwan Jia; Zheng Huang; Zhongzheng Li; Di Yang; Mengwei Huang; Chenxi Xiao; Fen Long; Jianchun Mao; Philip K Moore; Xinhua Liu; Yi Zhun Zhu
Journal:  Cell Mol Immunol       Date:  2018-05-29       Impact factor: 11.530

4.  JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation.

Authors:  Min-Young Youn; Atsushi Yokoyama; Sally Fujiyama-Nakamura; Fumiaki Ohtake; Ken-ichi Minehata; Hisataka Yasuda; Takeshi Suzuki; Shigeaki Kato; Yuuki Imai
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

5.  HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages.

Authors:  Soon-Duck Ha; Chae Young Han; Chantelle Reid; Sung Ouk Kim
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

6.  ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.

Authors:  Nidhi Rohatgi; Wei Zou; Patrick L Collins; Jonathan R Brestoff; Timothy H Chen; Yousef Abu-Amer; Steven L Teitelbaum
Journal:  Blood Adv       Date:  2018-10-09

7.  Metabolic-epigenetic coupling in osteoclast differentiation.

Authors:  Lionel B Ivashkiv
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

8.  BIX01294 suppresses osteoclast differentiation on mouse macrophage-like Raw264.7 cells.

Authors:  Hiromasa Tsuda; Ning Zhao; Kenichi Imai; Kuniyasu Ochiai; Pishan Yang; Naoto Suzuki
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

Review 9.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

10.  Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.

Authors:  Kazunori Hamamura; Nancy Tanjung; Hiroki Yokota
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.